In your interventional cardiology practice, which markers of risk, in the patient who has undergone a PCI, do you focus on to promote consideration for using a PCSK9 inhibitor?
In your interventional cardiology practice, which markers of risk, in the patient who has undergone a PCI, do you focus on to promote consideration for using a PCSK9 inhibitor?z
Created by
Presenter
Professor of Cardiology
Medical Director, Department of Cardiology
Charite University Hospital
Berlin, Germany